Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(0.83)
# 2161
Out of 5,333 analysts
128
Total ratings
45.45%
Success rate
-7.43%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
TDOC Teladoc Health | Maintains: In-Line | 8 7 | 7.12 | -1.69% | 3 | May 1, 2025 | |
ALGN Align Technology | Maintains: Outperform | 165 200 | 181.81 | 10% | 13 | May 1, 2025 | |
DGX Quest Diagnostics | Maintains: In-Line | 175 180 | 176.99 | 1.7% | 3 | Apr 23, 2025 | |
HCAT Health Catalyst | Downgrades: In-Line | 6 4 | 4.13 | -3.15% | 6 | Apr 9, 2025 | |
FTRE Fortrea Holdings | Maintains: In-Line | 20 15 | 6.13 | 144.7% | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 650 675 | 692.63 | -2.55% | 5 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 65 | 66.93 | -2.88% | 6 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 9 12 | 11.23 | 6.86% | 13 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 260 265 | 245.77 | 7.82% | 4 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 20 | 15.82 | 26.42% | 7 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 140 140 | 148.27 | -5.58% | 6 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 36 | 40 | -10% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 270 265 | 148.88 | 78% | 5 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 34 45 | 59.15 | -23.92% | 7 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 7 4 | 2.88 | 38.89% | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 23 | 17.61 | 30.61% | 3 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 23 20 | 25.05 | -20.16% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 5 5 | n/a | n/a | 3 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 12 16 | n/a | n/a | 2 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 25 39 | n/a | n/a | 2 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 185 | n/a | n/a | 9 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 7 5 | n/a | n/a | 1 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 12 | n/a | n/a | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 68 27 | 8.26 | 217.8% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 35 15 | 5.11 | 193.54% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 | 2.65 | 315.09% | 2 | Jan 4, 2022 |